Skip to main content
Top
Published in: Gastric Cancer 2/2017

01-03-2017 | Original Article

Diagnostic ability of magnifying endoscopy with blue laser imaging for early gastric cancer: a prospective study

Authors: Osamu Dohi, Nobuaki Yagi, Atsushi Majima, Yusuke Horii, Tomoko Kitaichi, Yuriko Onozawa, Kentaro Suzuki, Akira Tomie, Reiko Kimura-Tsuchiya, Toshifumi Tsuji, Nobuhisa Yamada, Nobukatsu Bito, Tetsuya Okayama, Naohisa Yoshida, Kazuhiro Kamada, Kazuhiro Katada, Kazuhiko Uchiyama, Takeshi Ishikawa, Tomohisa Takagi, Osamu Handa, Hideyuki Konishi, Yuji Naito, Akio Yanagisawa, Yoshito Itoh

Published in: Gastric Cancer | Issue 2/2017

Login to get access

Abstract

Background

Blue laser imaging (BLI) is a new image-enhanced endoscopy technique that utilizes a laser light source developed for narrow-band light observation. The aim of this study was to evaluate the usefulness of BLI for the diagnosis of early gastric cancer.

Methods

This single center prospective study analyzed 530 patients. The patients were examined with both conventional endoscopy with white-light imaging (C-WLI) and magnifying endoscopy with BLI (M-BLI) at Kyoto Prefectural University of Medicine between November 2012 and March 2015. The diagnostic criteria for gastric cancer using M-BLI included an irregular microvascular pattern and/or irregular microsurface pattern, with a demarcation line according to the vessel plus surface classification system. Biopsies of the lesions were taken after C-WLI and M-BLI observation. The primary end point of this study was to compare the diagnostic performance between C-WLI and M-BLI.

Results

We analyzed 127 detected lesions (32 cancers and 95 non-cancers). The accuracy, sensitivity, and specificity of M-BLI diagnoses were 92.1, 93.8, and 91.6 %, respectively. On the other hand, the accuracy, sensitivity, and specificity of C-WLI diagnoses were 71.7, 46.9, and 80.0 %, respectively.

Conclusions

M-BLI had improved diagnostic performance for early gastric cancer compared with C-WLI. These results suggested that the diagnostic effectiveness of M-BLI is similar to that of magnifying endoscopy with narrow-band imaging (M-NBI).
Literature
1.
go back to reference Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;15(127):2893–917.CrossRef Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;15(127):2893–917.CrossRef
2.
go back to reference Nakayoshi T, Tajiri H, Matsuda K, Kaise M, Ikegami M, Sasaki H. Magnifying endoscopy combined with narrow band imaging system for early gastric cancer: correlation of vascular pattern with histopathology (including video). Endoscopy. 2004;36:1080–4.CrossRefPubMed Nakayoshi T, Tajiri H, Matsuda K, Kaise M, Ikegami M, Sasaki H. Magnifying endoscopy combined with narrow band imaging system for early gastric cancer: correlation of vascular pattern with histopathology (including video). Endoscopy. 2004;36:1080–4.CrossRefPubMed
3.
go back to reference Yao K, Anagnostopoulos GK, Ragunath K. Magnifying endoscopy for diagnosing and delineating early gastric cancer. Endoscopy. 2009;41(5):462–7.CrossRefPubMed Yao K, Anagnostopoulos GK, Ragunath K. Magnifying endoscopy for diagnosing and delineating early gastric cancer. Endoscopy. 2009;41(5):462–7.CrossRefPubMed
4.
go back to reference Ezoe Y, Muto M, Horimatsu T, Minashi K, Yano T, Sano Y, et al. Magnifying narrow-band imaging versus magnifying white-light imaging for the differential diagnosis of gastric small depressive lesions: a prospective study. Gastrointest Endosc. 2010;71:477–84.CrossRefPubMed Ezoe Y, Muto M, Horimatsu T, Minashi K, Yano T, Sano Y, et al. Magnifying narrow-band imaging versus magnifying white-light imaging for the differential diagnosis of gastric small depressive lesions: a prospective study. Gastrointest Endosc. 2010;71:477–84.CrossRefPubMed
5.
go back to reference Kato M, Kaise M, Yonezawa J, Toyoizumi H, Yoshimura N, Yoshida Y, et al. Magnifying endoscopy with narrow-band imaging achieves superior accuracy in the differential diagnosis of superficial gastric lesions identified with white-light endoscopy: a prospective study. Gastrointest Endosc. 2010;72(3):523–9.CrossRefPubMed Kato M, Kaise M, Yonezawa J, Toyoizumi H, Yoshimura N, Yoshida Y, et al. Magnifying endoscopy with narrow-band imaging achieves superior accuracy in the differential diagnosis of superficial gastric lesions identified with white-light endoscopy: a prospective study. Gastrointest Endosc. 2010;72(3):523–9.CrossRefPubMed
6.
go back to reference Kiyotoki S, Nishikawa J, Satake M, Fukagawa Y, Shirai Y, Hamabe K, et al. Usefulness of magnifying endoscopy with narrow-band imaging for determining gastric tumor margin. J Gastroenterol Hepatol. 2010;25(10):1636–41.CrossRefPubMed Kiyotoki S, Nishikawa J, Satake M, Fukagawa Y, Shirai Y, Hamabe K, et al. Usefulness of magnifying endoscopy with narrow-band imaging for determining gastric tumor margin. J Gastroenterol Hepatol. 2010;25(10):1636–41.CrossRefPubMed
7.
go back to reference Ezoe Y, Muto M, Uedo N, Doyama H, Yao K, Oda I, et al. Magnifying narrowband imaging is more accurate than conventional white-light imaging in diagnosis of gastric mucosal cancer. Gastroenterology. 2011;141:2017–25.CrossRefPubMed Ezoe Y, Muto M, Uedo N, Doyama H, Yao K, Oda I, et al. Magnifying narrowband imaging is more accurate than conventional white-light imaging in diagnosis of gastric mucosal cancer. Gastroenterology. 2011;141:2017–25.CrossRefPubMed
8.
go back to reference Yamada S, Doyama H, Tao K, Uedo N, Ezoe Y, Oda I, et al. An efficient diagnostic strategy for small, depressed early gastric cancer with magnifying narrow-band imaging: a post hoc analysis of a prospective randomized controlled trial. Gastrointest Endosc. 2014;79(1):55–63.CrossRefPubMed Yamada S, Doyama H, Tao K, Uedo N, Ezoe Y, Oda I, et al. An efficient diagnostic strategy for small, depressed early gastric cancer with magnifying narrow-band imaging: a post hoc analysis of a prospective randomized controlled trial. Gastrointest Endosc. 2014;79(1):55–63.CrossRefPubMed
9.
go back to reference Yao K, Doyama H, Gotoda T, Ishikawa H, Nagahama T, Yokoi C, et al. Diagnostic performance and limitations of magnifying narrow-band imaging in screening endoscopy of early gastric cancer: a prospective multicenter feasibility study. Gastric Cancer. 2014;17(4):669–79.CrossRefPubMed Yao K, Doyama H, Gotoda T, Ishikawa H, Nagahama T, Yokoi C, et al. Diagnostic performance and limitations of magnifying narrow-band imaging in screening endoscopy of early gastric cancer: a prospective multicenter feasibility study. Gastric Cancer. 2014;17(4):669–79.CrossRefPubMed
10.
go back to reference Osawa H, Yamamoto H, Miure Y, Ajibe H, Shinhata H, Yoshizawa M, et al. Diagnosis of depressed-type early gastric cancer using small-caliber endoscopy with flexible spectral imaging color enhancement. Dig Endosc. 2012;24(4):231–6.CrossRefPubMed Osawa H, Yamamoto H, Miure Y, Ajibe H, Shinhata H, Yoshizawa M, et al. Diagnosis of depressed-type early gastric cancer using small-caliber endoscopy with flexible spectral imaging color enhancement. Dig Endosc. 2012;24(4):231–6.CrossRefPubMed
11.
go back to reference Osawa H, Yamamoto H, Miura Y, Yoshizawa M, Sunada K, Satoh K, et al. Diagnosis of extent of early gastric cancer using flexible spectral imaging color enhancement. World J Gastrointest Endosc. 2012;4(8):356–61.CrossRefPubMedPubMedCentral Osawa H, Yamamoto H, Miura Y, Yoshizawa M, Sunada K, Satoh K, et al. Diagnosis of extent of early gastric cancer using flexible spectral imaging color enhancement. World J Gastrointest Endosc. 2012;4(8):356–61.CrossRefPubMedPubMedCentral
12.
go back to reference Dohi O, Yagi N, Wada T, Yamada N, Bito N, Yamada S, et al. Recognition of endoscopic diagnosis in differentiated-type early gastric cancer by flexible spectral imaging color enhancement with indigo carmine. Digestion. 2012;86(2):161–70.CrossRefPubMed Dohi O, Yagi N, Wada T, Yamada N, Bito N, Yamada S, et al. Recognition of endoscopic diagnosis in differentiated-type early gastric cancer by flexible spectral imaging color enhancement with indigo carmine. Digestion. 2012;86(2):161–70.CrossRefPubMed
13.
go back to reference Yoshida N, Hisabe T, Inada Y, Kugai M, Yagi N, Hirai F, et al. The ability of a novel blue laser imaging system for the diagnosis of invasion depth of colorectal neoplasms. J Gastroenterol. 2014;49:73–80.CrossRefPubMed Yoshida N, Hisabe T, Inada Y, Kugai M, Yagi N, Hirai F, et al. The ability of a novel blue laser imaging system for the diagnosis of invasion depth of colorectal neoplasms. J Gastroenterol. 2014;49:73–80.CrossRefPubMed
14.
go back to reference Yoshida N, Yagi N, Inada Y, Kugai M, Okayama T, Kamada K, et al. The ability of a novel blue laser imaging system for the diagnosis of colorectal polyps. Dig Endosc. 2014;26:250–8.CrossRefPubMed Yoshida N, Yagi N, Inada Y, Kugai M, Okayama T, Kamada K, et al. The ability of a novel blue laser imaging system for the diagnosis of colorectal polyps. Dig Endosc. 2014;26:250–8.CrossRefPubMed
15.
go back to reference Osawa H, Yamamoto H. Present and future status of flexible spectral imaging color enhancement and blue laser imaging technology. Dig Endosc. 2014;26(Suppl. 1):105–15.CrossRefPubMed Osawa H, Yamamoto H. Present and future status of flexible spectral imaging color enhancement and blue laser imaging technology. Dig Endosc. 2014;26(Suppl. 1):105–15.CrossRefPubMed
16.
go back to reference Miyaki R, Yoshida S, Tanaka S, Kominami Y, Sanomura Y, Matsuo T, et al. A computer system to be used with laser-based endoscopy for quantitative diagnosis of early gastric cancer. J Clin Gastroenterol. 2015;49(2):108–15.CrossRefPubMed Miyaki R, Yoshida S, Tanaka S, Kominami Y, Sanomura Y, Matsuo T, et al. A computer system to be used with laser-based endoscopy for quantitative diagnosis of early gastric cancer. J Clin Gastroenterol. 2015;49(2):108–15.CrossRefPubMed
17.
go back to reference Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma—3rd English edition. Gastric Cancer. 2011;14:101–12.CrossRef Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma—3rd English edition. Gastric Cancer. 2011;14:101–12.CrossRef
18.
go back to reference Aoi T, Marusawa H, Sato T, Chiba T, Maruyama M. Risk of subsequent development of gastric cancer in patients with previous gastric epithelial neoplasia. Gut. 2006;55:588–9.CrossRefPubMedPubMedCentral Aoi T, Marusawa H, Sato T, Chiba T, Maruyama M. Risk of subsequent development of gastric cancer in patients with previous gastric epithelial neoplasia. Gut. 2006;55:588–9.CrossRefPubMedPubMedCentral
19.
go back to reference Fukase K, Kato M, Kikuchi S, Inoue K, Uemura N, Okamoto S, et al. Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an openlabel, randomised controlled trial. Lancet. 2008;372:392–7.CrossRefPubMed Fukase K, Kato M, Kikuchi S, Inoue K, Uemura N, Okamoto S, et al. Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an openlabel, randomised controlled trial. Lancet. 2008;372:392–7.CrossRefPubMed
20.
go back to reference Nakajima T, Oda I, Gotoda T, Hamanaka H, Eguchi T, Yokoi C, et al. Metachronous gastric cancers after endoscopic resection: how effective is annual endoscopic surveillance? Gastric Cancer. 2006;9:93–8.CrossRefPubMed Nakajima T, Oda I, Gotoda T, Hamanaka H, Eguchi T, Yokoi C, et al. Metachronous gastric cancers after endoscopic resection: how effective is annual endoscopic surveillance? Gastric Cancer. 2006;9:93–8.CrossRefPubMed
21.
go back to reference Natsugoe S, Natsugoe S, Matsumoto M, Okumura H, Ishigami S, Uenosono Y, et al. Multiple primary carcinomas with esophageal squamous cell cancer: clinicopathologic outcome. World J Surg. 2005;29:46–9.CrossRefPubMed Natsugoe S, Natsugoe S, Matsumoto M, Okumura H, Ishigami S, Uenosono Y, et al. Multiple primary carcinomas with esophageal squamous cell cancer: clinicopathologic outcome. World J Surg. 2005;29:46–9.CrossRefPubMed
22.
go back to reference Tatsuta M, Iishi H, Okuda S, Oshima A, Taniguchi H. Prospective evaluation of diagnostic accuracy of gastrofiberscopic biopsy in diagnosis of gastric cancer. Cancer. 1989;63:1415–20.CrossRefPubMed Tatsuta M, Iishi H, Okuda S, Oshima A, Taniguchi H. Prospective evaluation of diagnostic accuracy of gastrofiberscopic biopsy in diagnosis of gastric cancer. Cancer. 1989;63:1415–20.CrossRefPubMed
23.
go back to reference Yagi N, Naito Y, Dohi O, Yoshida N, Kamada K, Uchiyama K, et al. The efficacy of a novel blue LASER imaging system for the diagnosis of early gastric cancers; a prospective single center open trial. Gastrointest Endosc. 2013;77:Supplement AB458.CrossRef Yagi N, Naito Y, Dohi O, Yoshida N, Kamada K, Uchiyama K, et al. The efficacy of a novel blue LASER imaging system for the diagnosis of early gastric cancers; a prospective single center open trial. Gastrointest Endosc. 2013;77:Supplement AB458.CrossRef
Metadata
Title
Diagnostic ability of magnifying endoscopy with blue laser imaging for early gastric cancer: a prospective study
Authors
Osamu Dohi
Nobuaki Yagi
Atsushi Majima
Yusuke Horii
Tomoko Kitaichi
Yuriko Onozawa
Kentaro Suzuki
Akira Tomie
Reiko Kimura-Tsuchiya
Toshifumi Tsuji
Nobuhisa Yamada
Nobukatsu Bito
Tetsuya Okayama
Naohisa Yoshida
Kazuhiro Kamada
Kazuhiro Katada
Kazuhiko Uchiyama
Takeshi Ishikawa
Tomohisa Takagi
Osamu Handa
Hideyuki Konishi
Yuji Naito
Akio Yanagisawa
Yoshito Itoh
Publication date
01-03-2017
Publisher
Springer Japan
Published in
Gastric Cancer / Issue 2/2017
Print ISSN: 1436-3291
Electronic ISSN: 1436-3305
DOI
https://doi.org/10.1007/s10120-016-0620-6

Other articles of this Issue 2/2017

Gastric Cancer 2/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.